Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
3,20 | 2,94 | 3,20 | 2,94 | 3,20 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
16.2.2024 | 22:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
14.2.2024 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
13.2.2024 | 23:00 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
02.2.2024 | 22:38 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
17.11.2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
17.11.2023 | 22:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14.11.2023 | 22:12 | EDGAR2 | Form 8-K - Current report |
30.10.2023 | 13:20 | EDGAR2 | Form 8-K - Current report |
04.10.2023 | 23:03 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
04.10.2023 | 23:02 | EDGAR2 | Form 8-K - Current report |
17.8.2023 | 12:30 | EDGAR2 | Form 8-K - Current report |
14.8.2023 | 22:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
14.8.2023 | 22:15 | EDGAR2 | Form 8-K - Current report |
24.7.2023 | 22:16 | EDGAR2 | Form 8-K - Current report |